Contact Us
563-424-0365
Follow Us:
Time With Us!
Q:
TRD means you've tried two or more different antidepressant medications at adequate doses and for an adequate duration, but they haven't significantly improved your depression symptoms.
Q:
No. While both Spravato and ketamine affect the NMDA receptor, they are not the same. Spravato is a specific form of ketamine (esketamine) that has been developed and approved by the FDA for treatment-resistant depression and major depressive disorder with suicidal ideation or behavior. The delivery method, dosage, and monitoring procedures are also different. Ketamine is not FDA approved for the treatment of depression and is used "off-label" when prescribed for mental health conditions. This means its use is not under the same level of regulatory control as Spravato.
Q:
Spravato is a nasal spray medication, used in conjunction with an oral antidepressant, for adults with treatment-resistant depression (TRD). It is also approved for adults with major depressive disorder (MDD) with suicidal ideation or behavior.
Q:
Spravato works differently than traditional antidepressants. It targets a different receptor in the brain, the NMDA receptor, and is believed to help regulate glutamate, a brain chemical involved in mood. This different mechanism may lead to faster symptom relief for some individuals.
Follow Us
*
More
Contact Us
(563) 424-0136
1225 East River Drive Suite 340
Monday - Friday, 9:00 am - 5:00 pm
© Copyright 2025. HCLZ Solutions. All rights reserved.